 M34 |
 |
Systemic sclerosis [scleroderma]  |
| |
| Excludes1 |
circumscribed scleroderma (L94.0)
neonatal scleroderma (P83.88)
|
|
| |
 M34.0 |
|
Progressive systemic sclerosis |
|
| |
| M34.1 |
|
CR(E)ST syndrome |
| |
| Combination of calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, telangiectasia |
|
|
| |
| M34.2 |
|
Systemic sclerosis induced by drug and chemical |
| |
| CodeFirst |
poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)
|
| UseAdditionalCode |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
|
|
|
| |
| M34.8 |
|
Other forms of systemic sclerosis |
| |
| M34.81 |
|
Systemic sclerosis with lung involvement |
| |
| CodeAlso |
if applicable:
other interstitial pulmonary diseases (J84.89)
secondary pulmonary arterial hypertension (I27.21)
|
|
| | |
| M34.82 |
|
Systemic sclerosis with myopathy |
| | |
| M34.83 |
|
Systemic sclerosis with polyneuropathy |
| | |
| M34.89 |
|
Other systemic sclerosis |
| |
| |
| M34.9 |
|
Systemic sclerosis, unspecified |
|